Executive Director, Global Business Development, Transactions

Initial Therapeutics, Inc.; Basking Ridge (NJ); On-site; USD 255,000 - 425,000; Full time

Job summary

Daiichi Sankyo, Inc. seeks an Executive Director of Global Business Development – Transactions with deep oncology experience to lead deal making from licensing to co-promotion and acquisitions.

The role involves identifying and prioritizing opportunities, coordinating cross-functional teams, and driving negotiations to close strategic agreements. The ideal candidate has a strong financial background and a proven track record of leading complex oncology transactions, including collaboration with

Qualifications

• 10+ years within the pharmaceutical industry, with Big Pharma experience.
• Proven ability to lead complex negotiations in oncology transactions.
• Track record of managing teams and mentoring junior personnel.

Responsibilities

• Execute transactions through proposal, review, and negotiation of NBAs and Definitive Agreements.
• Lead for opportunities as assigned by VP Global BD; coordinate with R&D Finance, Legal, and others.

Skills

Deal leadership

Negotiation

Financial analysis

Oncology experience

Partnerships/licensing

Education

MBA (finance)

Master’s in Engineering/Finance

PhD

MD

JD with transaction expertise

Bachelor’s Degree

Job description

Executive Director, Global Business Development, Transactions

At Daiichi Sankyo, we are united by a single purpose, to improve lives around the world through innovative medicines. With a legacy of innovation since 1899, a presence in more than 30 countries, and more than 19,000 employees, we are advancing breakthrough therapies in oncology, cardiovascular disease, rare diseases, and immune disorders. Guided by our 2030 vision to "be an innovative global healthcare company contributing to the sustainable development of society", we are shaping a healthier, more hopeful future for patients, their families, and society.

Job Summary

The candidate for Executive Director, Global Business Development – Transactions will possess a strong business acumen with extensive experience in the life sciences and biopharmaceutical industry particularly in the area of Oncology. Expertise and prior experience in the deal making process in the industry as evidenced by a comprehensive deal sheet indicating prior successful deal leadership to closing across the range of counterparties/collaboration partners typically encountered by the Daiichi Sankyo Transactions team is required. The candidate will lead efforts in partnering/licensing for research, development, and commercialization of therapies with a particular focus in Oncology. The purpose of this job is to identify, coordinate the assessment of, and help secure pipeline‑and portfolio‑enhancing, business opportunities (through licensing, acquisition, co‑promotion, and other structures).

Responsibilities

Execute assigned transactions through proposal/review/negotiation of NBTS and Definitive Agreements, acting as Lead for many opportunities as assigned by the Vice President Global Business Development.
Work in concert with key Functional Area Leads (R&D Finance, R&D Global Project Team Leader, Business Development, Legal and others) and Senior Management to secure alignment on key terms and conditions prior to and during active negotiations.
Communicate activities frequently across the organization through related internal approval committees, sharing key contract terms and strategic, financial, scientific and commercial rationale for each opportunity.
Respond to Q&A from corporate stakeholders.
Meet with other pharmaceutical licensing groups, participate in industry meetings, conduct proactive product searches and coordinate search efforts to identify new opportunities.
Coordinate with commercial, R&D, finance, supply chain, intellectual property, legal, etc., on both preliminary and full assessments of potential opportunities, and summarize conclusions and recommendations for senior management.
Schedule and lead diligence meetings with potential partners.
Provide strategic alliance management for deals to monitor compliance, resolve strategic issues and re‑negotiate if necessary.
Assure functional excellence by training and developing junior staff and direct reports.

Qualifications

• Education: MBA with a strong finance focus preferred. Master’s Degree in Engineering Management or Finance preferred. PhD preferred. MD preferred. JD acceptable if accompanied by proven transaction expertise. Bachelor’s Degree required.
• Experience: 10+ years within the pharmaceutical industry, with Big Pharma experience required. Proven ability to lead complex negotiations in oncology transactions. Track record of managing teams, coaching staff, and mentoring junior personnel. Matrix experience preferred. Branded Oncology transaction experience required. Strong financial expertise and independent transaction leadership. Deal sheet required. Companion diagnostic contracting expertise strongly preferred. Expertise in contract negotiations and closing complex oncology deals. Experience with co‑development/co‑commercialization agreements, joint ventures, clinical trial agreements, material transfer agreements, divestitures, in/out‑licensing, acquisitions, academic research agreements, and venture capital investments.
• Travel: Ability to travel up to 30% of the time, including frequent overnight travel domestically and some global travel.

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.

Salary Range: USD$255,000.00 - USD$425,000.00